生产、销售假药、劣药犯罪的规范内涵:属性、辨析与路径

THE NORMATIVE CONNOTATION OF THE CRIME OF PRODUCING AND SELLING FAKE AND INFERIOR DRUGS: ATTRIBUTE, DISCRIMINATION AND PATH

《刑法修正案(十一)》对生产、销售假药、劣药犯罪的有关规定进行修改,引起一系列理论与实践争议。生产、销售假药、劣药犯罪删除了“依照《药品管理法》”认定假药、劣药的罪状表述,但这并不能否定该类药品犯罪的法定犯属性。妨害药品管理罪与生产、销售假药、劣药犯罪均是《刑法修正案(十一)》时代下的法定犯,二者既存在交叉竞合关系,又有各自的违法评价范围与评价重心,不可混淆。在药品认定标准与前置法脱钩的规范背景下,刑法上假药、劣药的认定虽仍以《药品管理法》第98条为形式参考,但更应当结合刑法的法益保护原则独立判断假药、劣药的实质范围。

The Criminal Law Amendment(XI)amends the relevant provisions on the crime of producing and selling fake and inferior drugs,giving rise to a series of theoretical and practical controversies.The crime of producing and selling fake and inferior drugs has deleted the expression of the crime of identifying fake and inferior drugs“according to the Drug Administration Law”,but it does not negate the legal crime nature of related drugs crimes.The crime of hindering drugs administration and the crime of producing and sell-ing fake and inferior drugs are both legal crimes under the Criminal Law Amendment(XI)era.They not only have a cross-competition and cooperation relationship,but also have their own scope and focus of illegal evaluation,which should not be confused.Under the background of decoupling of drugs identification standard and pre-law,although the identification of fake and inferior drugs in criminal law still takes Article 98 of Drug Administration Law as the formal reference,the substantial scope of fake and inferior drugs should be judged independently according to the principle of legal interest protection in criminal law.